Advances in the discovery of selective NaV1.8 inhibitors for pain management.

Pain management remains an unmet healthcare need, particularly in the development of effective non-opioid analgesics with improved safety profiles. Among emerging molecular targets, the voltage-gated sodium channel NaV1.8 has garnered significant att…

Preview only. Read the full abstract at the source